Literature DB >> 18228249

Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.

Shilpa Sant1, Suzie Poulin, Patrice Hildgen.   

Abstract

The aim of the present study was to evaluate the cellular interaction of nanoparticles (NPs) prepared from different pegylated polymers and elucidate the effect of polymer architecture, for instance, grafted versus block copolymer on their cellular uptake. Fluorescein-labeled NPs of four different polymers, viz., poly(D,L-lactide) (PLA), poly(ethylene glycol)(1%)-graft-poly(D,L-lactide) (PEG(1%)-g-PLA), poly(ethylene glycol)(5%)-graft-poly(D,L-lactide) (PEG(5%)-g-PLA), and (poly(D,L-lactide)-block-poly(ethylene glycol)-block-poly(D,L-lactide))(n) multiblock copolymer (PLA-PEG-PLA)(n) were prepared. These NPs were characterized for their size, zeta-potential, and surface morphology. XPS studies revealed possibility of chemical interaction between PLA-COOH groups and PVA-OH groups, thus making it difficult to be washed off the NP surface completely. Grafted polymer NPs showed more surface PEG coverage than (PLA-PEG-PLA)(n) despite of their comparatively lower PEG content. The results of surface properties were translated into protein binding showing least amount of proteins bound to grafted copolymer NPs as against multiblock copolymer NPs. NPs showed no toxicity to RAW 264.7 cells. Cellular uptake of NPs was temperature and concentration-dependent as well as involved clathrin-mediated processes. Thus, this study confirms the importance of polymer architecture in determining the surface properties and hence, protein binding and cellular interactions of NPs. Also, it was shown that grafted copolymer NPs reduced macrophage uptake as compared to multiblock copolymer although mechanisms different than phagocytosis were involved. 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18228249     DOI: 10.1002/jbm.a.31800

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  17 in total

1.  Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes.

Authors:  Eleni Samaridou; Nikolaos Kalamidas; Irene Santalices; José Crecente-Campo; Maria José Alonso
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 2.  Development of functional biomaterials with micro- and nanoscale technologies for tissue engineering and drug delivery applications.

Authors:  Hojae Bae; Hunghao Chu; Faramarz Edalat; Jae Min Cha; Shilpa Sant; Aditya Kashyap; Amir F Ahari; Chung Hoon Kwon; Jason W Nichol; Sam Manoucheri; Behnam Zamanian; Yadong Wang; Ali Khademhosseini
Journal:  J Tissue Eng Regen Med       Date:  2012-06-18       Impact factor: 3.963

3.  Phosphonomethyl iminodiacetic acid-conjugated cobalt oxide nanoparticles liberate Co(++) ion-induced stress associated activation of TNF-α/p38 MAPK/caspase 8-caspase 3 signaling in human leukemia cells.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Satyajit Tripathy; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2014-12-23       Impact factor: 3.358

4.  Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules.

Authors:  Nicholas M Molino; Kateryna Bilotkach; Deborah A Fraser; Dongmei Ren; Szu-Wen Wang
Journal:  Biomacromolecules       Date:  2012-03-14       Impact factor: 6.988

5.  NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.

Authors:  Ari S Nowacek; Reagan L Miller; Joellyn McMillan; Georgette Kanmogne; Michel Kanmogne; R Lee Mosley; Zhiya Ma; Sabine Graham; Mahesh Chaubal; Jane Werling; Barrett Rabinow; Huanyu Dou; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-12       Impact factor: 5.307

Review 6.  Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.

Authors:  Simi Gunaseelan; Krishnan Gunaseelan; Manjeet Deshmukh; Xiaoping Zhang; Patrick J Sinko
Journal:  Adv Drug Deliv Rev       Date:  2009-11-24       Impact factor: 15.470

7.  Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA).

Authors:  Sachin S Chandran; Sangeeta R Banerjee; Ron C Mease; Martin G Pomper; Samuel R Denmeade
Journal:  Cancer Biol Ther       Date:  2008-03-26       Impact factor: 4.742

Review 8.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

Review 9.  Hypoxic tumor microenvironment: Opportunities to develop targeted therapies.

Authors:  Akhil Patel; Shilpa Sant
Journal:  Biotechnol Adv       Date:  2016-04-30       Impact factor: 14.227

10.  Stealth properties to improve therapeutic efficacy of drug nanocarriers.

Authors:  Stefano Salmaso; Paolo Caliceti
Journal:  J Drug Deliv       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.